Does TEDUGLUTIDE Cause Basal cell carcinoma? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Basal cell carcinoma have been filed in association with TEDUGLUTIDE (Gattex). This represents 0.2% of all adverse event reports for TEDUGLUTIDE.
14
Reports of Basal cell carcinoma with TEDUGLUTIDE
0.2%
of all TEDUGLUTIDE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Basal cell carcinoma From TEDUGLUTIDE?
Of the 14 reports, 4 (28.6%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEDUGLUTIDE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TEDUGLUTIDE Cause?
Vascular device infection (1,009)
Weight decreased (991)
Product dose omission issue (937)
Diarrhoea (779)
Abdominal pain (714)
Nausea (682)
Weight increased (631)
Dehydration (615)
Vomiting (585)
Death (527)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which TEDUGLUTIDE Alternatives Have Lower Basal cell carcinoma Risk?
TEDUGLUTIDE vs TEDUGLUTIDE\WATER
TEDUGLUTIDE vs TEGAFUR
TEDUGLUTIDE vs TEGAFUR\URACIL
TEDUGLUTIDE vs TEGASEROD
TEDUGLUTIDE vs TEGRETOL